TESAMORELIN
WEEKEND15
Product Name: Tesamorelin Common Name / Alias: Tesamorelin Acetate Catalog Number: TES-xxx (e.g., TES-5MG) CAS Number: 901758-09-6 Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S Molecular Weight: 5135.89 Da (approx.) Sequence: Synthetic 44-amino acid peptide (modified GHRH analog) Quantity Options: 5 mg / 10 mg per vial (custom available) Form: Lyophilized powder Appearance: White to off-white powder Purity: ≥99% (HPLC) Grade: Research Grade
Intended Use: For Research Use Only (RUO). Not for human or veterinary use. Not for diagnostic or therapeutic purposes. Strictly intended for laboratory and in-vitro research applications.
Product Description
Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog. It is studied in research settings for its role in stimulating the pituitary gland to release endogenous growth hormone. Researchers use it to investigate the growth hormone axis, metabolic regulation, and related endocrine pathways.
Research Applications
Growth hormone axis and pituitary function studies
Metabolic regulation and body composition research
Lipodystrophy and fat metabolism models
Age-related hormone decline investigations
IGF-1 pathway and downstream signaling analysis
Comparative studies with other GHRH analogs or secretagogues
Storage and Handling
Short-term storage: 2–8°C
Long-term storage: -20°C (desiccated, protected from light)
Reconstitution: Use sterile bacteriostatic water or appropriate buffer per your protocol
Stability: Stable for 24+ months under recommended conditions when properly stored
Use standard laboratory PPE and aseptic techniques
Quality Control
Third-party HPLC purity and identity verification
Mass spectrometry confirmation
Certificate of Analysis (COA) provided with each batch
Batch-specific documentation available upon request
Safety and Regulatory Information
Disclaimer: This product is sold strictly for laboratory research purposes only. Aureum Research assumes no liability for any use outside of intended research applications.
FDA Note (Compliance Reminder): Tesamorelin is an FDA-approved prescription drug (under the brand name Egrifta) for specific medical indications. However, this product is offered exclusively for research use and is notintended for human consumption or clinical applications. All marketing and labeling must remain strictly within RUO guidelines to maintain full regulatory compliance.
Hazards: Handle as a potent bioactive research peptide. Refer to the Safety Data Sheet (SDS) for detailed information.
Shipping: Ships as a non-hazardous research chemical.
Warning: Keep out of reach of unauthorized personnel. Not for food, drug, cosmetic, or household use.